Leurubicin - CISMeF

Preferred Label : Leurubicin;

NCIt definition : An N-L-leucyl prodrug of the anthracycline doxorubicin, with antineoplastic activity. Leurubicin is converted to its active form doxorubicin in or on tumor cells by hydrolytic enzymes.;

UNII : 1Z20MGK851;

InChIKey : HROXIDVVXKDCBD-ZUWKMVCBSA-N;

CAS number : 70774-25-3;

Chemical formula : C33H40N2O12;

Détails

Origin ID

C81421;

UMLS CUI

C2825623;

Automatic exact mappings (from CISMeF team)
- N-leucyldoxorubicin [MeSH concept]
- N-leucyldoxorubicin [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
concept_is_in_subset
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]
- GDC Terminology [NCIt concept]
- GDC Therapeutic Agent Terminology [NCIt concept]
- GDC Value Terminology [NCIt concept]
- NCIt Antineoplastic Agent Terminology [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients